The ATTC is coordinated as part of the Cell and Gene Therapy Catapult, and operates within the NHS framework More: Innovate UK funded NA-ATTC adds three new industry partners Source: News
read moreKeytruda plus chemotherapy demonstrated superior overall survival rate in this patient population in the KEYNOTE-826 trial More: FDA clears Keytruda for first-line cervical cancer Source: News
read moreThe measures include a £250m ‘winter access fund’ from NHS England More: NHS publishes new plans to improve patient access to GP appointments Source: News
read more26 experts have been appointed to join the Scientific Advisory Group on the Origins of Novel Pathogens (Sago) More: New WHO group could be ‘the last to find virus origins’ Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals